Search

Your search keyword '"Kunz, Wolfgang G"' showing total 753 results
Start Over Author "Kunz, Wolfgang G"
753 results on '"Kunz, Wolfgang G"'

9. Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy

Author

Voltin, Conrad-Amadeus, Paccagnella, Andrea, Winkelmann, Michael, Heger, Jan-Michel, Casadei, Beatrice, Beckmann, Laura, Herrmann, Ken, Dekorsy, Franziska J., Kutsch, Nadine, Borchmann, Peter, Fanti, Stefano, Kunz, Wolfgang G., Subklewe, Marion, Kobe, Carsten, Zinzani, Pier Luigi, Stelljes, Matthias, Roth, Katrin S., Drzezga, Alexander, Noppeney, Richard, Rahbar, Kambiz, Reinhardt, H. Christian, von Tresckow, Bastian, Seifert, Robert, Albring, Jörn C., Blumenberg, Viktoria, Farolfi, Andrea, Flossdorf, Sarah, Gödel, Philipp, and Hanoun, Christine

Published
2024
Full Text
View/download PDF

10. Cost-effectiveness of CT perfusion for the detection of large vessel occlusion acute ischemic stroke followed by endovascular treatment: a model-based health economic evaluation study

Author

van Voorst, Henk, Hoving, Jan W., Koopman, Miou S., Daems, Jasper D., Peerlings, Daan, Buskens, Erik, Lingsma, Hester F., Beenen, Ludo F. M., de Jong, Hugo W. A. M., Berkhemer, Olvert A., van Zwam, Wim H., Roos, Yvo B. W. E. M., van Walderveen, Marianne A. A., van den Wijngaard, Ido, Dippel, Diederik W. J., Yoo, Albert J., Campbell, Bruce C. V., Kunz, Wolfgang G., Emmer, Bart J., and Majoie, Charles B. L. M.

Published
2024
Full Text
View/download PDF

12. Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma – A retrospective multicenter study of the Bavarian university hospitals

Author

Burkhard-Meier, Anton, Grube, Matthias, Jurinovic, Vindi, Agaimy, Abbas, Albertsmeier, Markus, Berclaz, Luc M., Di Gioia, Dorit, Dürr, Hans Roland, von Eisenhart-Rothe, Rüdiger, Eze, Chukwuka, Fechner, Katja, Fey, Emma, Güler, Sinan E., Hecker, Judith S., Hendricks, Anne, Keil, Felix, Klein, Alexander, Knebel, Carolin, Kovács, Julia R., Kunz, Wolfgang G., Lenze, Ulrich, Lörsch, Alisa M., Lutz, Mathias, Meidenbauer, Norbert, Mogler, Carolin, Schmidt-Hegemann, Nina-Sophie, Semrau, Sabine, Sienel, Wulf, Trepel, Martin, Waldschmidt, Johannes, Wiegering, Armin, and Lindner, Lars H.

Published
2024
Full Text
View/download PDF

14. Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial

Author

Holzgreve, Adrien, Unterrainer, Marcus, Calais, Jérémie, Adams, Thaiza, Oprea-Lager, Daniela E., Goffin, Karolien, Lopci, Egesta, Unterrainer, Lena M., Kramer, Kristina K. M., Schmidt-Hegemann, Nina-Sophie, Casuscelli, Jozefina, Stief, Christian G., Ricke, Jens, Bartenstein, Peter, Kunz, Wolfgang G., and Mehrens, Dirk

Published
2023
Full Text
View/download PDF

15. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich

Author

Zhang, Danmei, Dorman, Klara, Heinrich, Kathrin, Weiss, Lena, Boukovala, Myrto, Haas, Michael, Greif, Philipp A., Ziemann, Frank, Beyer, Georg, Roessler, Daniel, Goni, Elisabetta, Renz, Bernhard, D’Haese, Jan G., Kunz, Wolfgang G., Seidensticker, Max, Corradini, Stefanie, Niyazi, Maximilian, Ormanns, Steffen, Kumbrink, Jörg, Jung, Andreas, Mock, Andreas, Rudelius, Martina, Klauschen, Frederick, Werner, Jens, Mayerle, Julia, von Bergwelt-Baildon, Michael, Boeck, Stefan, Heinemann, Volker, and Westphalen, C. Benedikt

Published
2023
Full Text
View/download PDF

16. Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE

Author

Unterrainer, Marcus, Kunte, Sophie C., Unterrainer, Lena M., Holzgreve, Adrien, Delker, Astrid, Lindner, Simon, Beyer, Leonie, Brendel, Matthias, Kunz, Wolfgang G., Winkelmann, Michael, Cyran, Clemens C., Ricke, Jens, Jurkschat, Klaus, Wängler, Carmen, Wängler, Björn, Schirrmacher, Ralf, Belka, Claus, Niyazi, Maximilian, Tonn, Joerg-Christian, Bartenstein, Peter, and Albert, Nathalie L.

Published
2023
Full Text
View/download PDF

18. Indeterminate Retroperitoneal Masses

Author

Messiou, Christina, Kunz, Wolfgang G., Hodler, Juerg, Series Editor, Kubik-Huch, Rahel A., Series Editor, von Schulthess, Gustav K., Series Editor, and Roos, Justus E., editor

Published
2023
Full Text
View/download PDF

20. Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment

Author

Holzgreve, Adrien, Taugner, Julian, Käsmann, Lukas, Müller, Philipp, Tufman, Amanda, Reinmuth, Niels, Li, Minglun, Winkelmann, Michael, Unterrainer, Lena M., Nieto, Alexander E., Bartenstein, Peter, Kunz, Wolfgang G., Ricke, Jens, Belka, Claus, Eze, Chukwuka, Unterrainer, Marcus, and Manapov, Farkhad

Published
2023
Full Text
View/download PDF

21. Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

Author

Dorman, Klara, Zhang, Danmei, Heinrich, Kathrin, Reeh, Laurens, Weiss, Lena, Haas, Michael, Beyer, Georg, Rössler, Daniel, Goni, Elisabetta, Renz, Bernhard W., D’Haese, Jan G., Kunz, Wolfgang G., Seidensticker, Max, Corradini, Stefanie, Niyazi, Maximilian, Ormanns, Steffen, Kumbrink, Jörg, Jung, Andreas, Klauschen, Frederick, Werner, Jens, Mayerle, Julia, von Bergwelt-Baildon, Michael, Boeck, Stefan, Heinemann, Volker, and Westphalen, C. Benedikt

Published
2023
Full Text
View/download PDF

22. A Prospective Multicenter Registry on Feasibility, Safety, and Outcome of Endovascular Recanalization in Childhood Stroke (Save ChildS Pro)

Author

Sporns, Peter B, Kemmling, André, Lee, Sarah, Fullerton, Heather, Kunz, Wolfgang G, Wilson, Jenny L, Mackay, Mark T, Steinlin, Maja, Fiehler, Jens, Psychogios, Marios, and Wildgruber, Moritz

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Neurosciences, Clinical Research, Pediatric, Clinical Trials and Supportive Activities, Stroke, Brain Disorders, stroke, ischemic stroke, arterial ischemic stroke, thrombectomy, mechanical thrombectomy, intravenous thrombolysis, childhood stroke, pediatric stroke, Psychology, Clinical sciences, Biological psychology
Abstract

Rationale: Early evidence for the benefit of mechanical thrombectomy (MT) in pediatric patients with intracranial large vessel occlusion has been shown in previous retrospective cohorts. Higher-level evidence is needed to overcome the limitations of these studies such as the lack of a control group and the retrospective design. Randomized trials will very likely not be feasible, and several open questions remain, for example, the impact of arteriopathic etiologies or a possible lower age limit for MT. Save ChildS Pro therefore aims to demonstrate the safety and effectiveness of MT in pediatric patients compared to the best medical management and intravenous thrombolysis. Design: Save ChildS Pro is designed as a worldwide multicenter prospective registry comparing the safety and effectiveness of MT to the best medical care alone in the treatment of pediatric arterial ischemic stroke (AIS). It will include pediatric patients (

Published
2021

26. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022

Author

Andreou, Dimosthenis, Barth, Thomas, Bauer, Sebastian, Blay, Jean-Yves, Blum, Veronika, Bode, Beata, Bonvalot, Sylvie, Bovee, Judith, Braam, Petra, Brodowicz, Thomas, Broto, Jean Martin, Dei Tos, Angelo, Denschlag, Dominik, Desar, Ingrid, Digklia, Antonia, Dileo, Palma, Dirksen, Uta, Douchy, Thomas, Duffaud, Florence, Eriksson, Mikael, Fröhling, Stefan, Gelderblom, Hans, Gronchi, Alessandro, Haas, Rick, Hardes, Jenrik, Hartmann, Wolfgang, Hofer, Silvia, Hohenberger, Peter, Hompes, Daphne, Huang, Paul, Italiano, Antoine, Jakob, Jens, Jones, Robin, Judson, Ian, Köhler, Günter, Kollàr, Attila, Krasniqi, Fatime, Krol, Stijn, Kunz, Wolfgang, Le Grange, Franel, Le Pechoux, Cécile, LeCesne, Alexandre, Leithner, Andreas, Liegl-Atzwanger, Bernadette, Lindner, Lars, Mechtersheimer, Gunhild, Messiou, Christina, Miah, Aisha, Pink, Daniel, Reichardt, Peter, Romagosa, Cleo, Rothermundt, Christian, Rutkowski, Piotr, Safwat, Akmel, Sangalli, Claudia, Szkandera, Joanna, Thway, Khin, Tunn, Per-Ulf, Van der Graaf, Winette, Van Houdt, Winan, Wardelmann, Eva, Zachariah, Ralph, Botter, Sander, Cerny, Thomas, Desar, Ingrid M.E., Jones, Robin L., Kunz, Wolfgang G., Liegl-Atzwanger, Berndadette, Lindner, Lars H., Miah, Aisha B., van der Graaf, Winette T.A., and van Houdt, Winan J.

Published
2023
Full Text
View/download PDF

30. Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation

Author

Unterrainer, Marcus, Deroose, Christophe M., Herrmann, Ken, Moehler, Markus, Blomqvist, Lennart, Cannella, Roberto, Caramella, Caroline, Caruso, Damiano, Chouhan, Manil D., Denecke, Timm, De la Pinta, Carolina, De Geus-Oei, Lioe-Fee, Dulskas, Audrius, Eisenblätter, Michel, Foley, Kieran G., Gourtsoyianni, Sofia, Lecouvet, Frederic E., Lopci, Egesta, Maas, Monique, Obmann, Markus M., Oprea-Lager, Daniela E., Verhoeff, Joost J.C., Santiago, Ines, Terraz, Sylvain, D'Anastasi, Melvin, Regge, Daniele, Laghi, Andrea, Beets-Tan, Regina G.H., Heinemann, Volker, Lordick, Florian, Smyth, Elizabeth C., Ricke, Jens, and Kunz, Wolfgang G.

Published
2022
Full Text
View/download PDF

31. Image-Guided Embolotherapy of Arteriovenous Malformations of the Face

Author

Schmidt, Vanessa F., Masthoff, Max, Brill, Richard, Sporns, Peter B., Köhler, Michael, Schulze-Zachau, Victor, Takes, Martin, Ehrl, Denis, Puhr-Westerheide, Daniel, Kunz, Wolfgang G., Shemwetta, Mwivano Dunstan, Mbuguje, Eric M., Naif, Azza A., Sarkar, Abizer, Ricke, Jens, Seidensticker, Max, Wohlgemuth, Walter A., and Wildgruber, Moritz

Published
2022
Full Text
View/download PDF

32. Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patients.

Author

Haebe, Sarah, Schuebbe, Gesa, Jurmeister, Philipp, von Bergwelt-Baildon, Michael, Westphalen, C. Benedikt, Lauer, Ulrich M., Kunz, Wolfgang G., Subklewe, Marion, and Weigert, Oliver

Subjects
MEDICAL sciences, IMMUNE checkpoint inhibitors, CHEMORADIOTHERAPY, PROGRAMMED death-ligand 1, NASOPHARYNX
Abstract

Rare cancers present significant challenges in diagnosis, treatment, and research, accounting for up to 25% of global cancer cases. Due to their rarity and atypical presentations, they are often misdiagnosed, resulting in late-stage detection and poor outcomes. Here, we describe a patient case with advanced metastatic nasopharynx NUT carcinoma, one of the rarest and most aggressive cancers. We conducted a comprehensive analysis of this patient's tumor, including Tumor Mutation Burden, Microsatellite Instability, and genetic profiling to explore further putative druggable targets. The tumor exhibited high PD-L1 expression and showed a notable response to immune checkpoint inhibitors when combined with platinum-based radio-chemotherapy. Our findings indicate that checkpoint inhibitors could play a critical role in treating NUT carcinoma, offering new therapeutic avenues and hope for patients with this challenging diagnosis. Whether PD-L1 expression may be a useful predictor of immune checkpoint inhibitor efficacy warrants further research. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

33. Optimizing Radiation Dose and Image Quality in Stroke CT Protocols: Proposed Diagnostic Reference Levels for Multiphase CT Angiography and Perfusion Imaging.

Author

Forbrig, Robert, Trumm, Christoph G., Reidler, Paul, Kunz, Wolfgang G., Dimitriadis, Konstantinos, Kellert, Lars, Rückel, Johannes, Liebig, Thomas, and Stahl, Robert

Subjects
ISCHEMIC stroke, CONE beam computed tomography, PERFUSION imaging, MEDIAN (Mathematics), BRAIN tomography
Abstract

Objective: In suspected acute ischemic stroke, it is now reasonable to expand the conventional "stroke protocol" (non-contrast computed tomography (NCCT), arterial CT angiography (CTA), and optionally CT perfusion (CTP)) to early and late venous head scans yielding a multiphase CTA (MP-CTA) to increase diagnostic confidence. Diagnostic reference levels (DRLs) have been defined for neither MP-CTA nor CTP. We therefore present dosimetry data, while also considering image quality, for a large, unselected patient cohort. Methods: A retrospective single-center study of 1790 patients undergoing the extended stroke protocol with three scanners (2× dual-source, DSCT; 1× single-source, SSCT) between 07/21 and 12/23 was conducted. For each sequence, we analyzed the radiation dose (volumetric CT dose index (CTDIvol); dose length product; effective dose); objective image quality using manually placed regions of interest (contrast-to-noise ratio (CNR)); and subjective image quality (4-point scale: 1 = non-diagnostic, 4 = excellent). The DRL was defined as the 75% percentile of the CTDIvol distribution. The Kruskal-Wallis test was used initially to test for overall equality of median values in each data group. Single post-test comparisons were performed with Dunn's test, with an overall statistical significance level of 0.05. Results: Dosimetry values were significantly higher for SSCT (p < 0.001, each). Local DRLs ranged between 37.3 and 49.1 mGy for NCCT, 3.6–5.5 mGy for arterial CTA, 1.2–2.5 mGy each for early/late venous CTA, and 141.1–220.5 mGy for CTP. Protocol adjustment (DSCT-1: CTP) yielded a 28.2% dose reduction. The highest/lowest CNRs (arterial/early venous CTA, respectively) were recorded for SSCT/DSCT-2 (p < 0.001). Subjective image quality was rated excellent except for slightly increased MP-CTA noise at DSCT-2 (median = 3). Conclusions: Our data imply that additive MP-CTA scans only yield a minor increase in radiation exposure, particularly when using DSCT. CTP should be limited to selected patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [18F]SiTATE

Author

Unterrainer, Marcus, Kunte, Sophie C., Unterrainer, Lena M., Holzgreve, Adrien, Delker, Astrid, Lindner, Simon, Beyer, Leonie, Brendel, Matthias, Kunz, Wolfgang G., Winkelmann, Michael, Cyran, Clemens C., Ricke, Jens, Jurkschat, Klaus, Wängler, Carmen, Wängler, Björn, Schirrmacher, Ralf, Belka, Claus, Niyazi, Maximilian, Tonn, Joerg‑Christian, Bartenstein, Peter, and Albert, Nathalie L.

Published
2023
Full Text
View/download PDF

37. Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC

Author

deSouza, Nandita M., van der Lugt, Aad, Deroose, Christophe M., Alberich-Bayarri, Angel, Bidaut, Luc, Fournier, Laure, Costaridou, Lena, Oprea-Lager, Daniela E., Kotter, Elmar, Smits, Marion, Mayerhoefer, Marius E., Boellaard, Ronald, Caroli, Anna, de Geus-Oei, Lioe-Fee, Kunz, Wolfgang G., Oei, Edwin H., Lecouvet, Frederic, Franca, Manuela, Loewe, Christian, Lopci, Egesta, Caramella, Caroline, Persson, Anders, Golay, Xavier, Dewey, Marc, O’Connor, James P. B., deGraaf, Pim, Gatidis, Sergios, and Zahlmann, Gudrun

Published
2022
Full Text
View/download PDF

38. Clinically focused multi-cohort benchmarking as a tool for external validation of artificial intelligence algorithm performance in basic chest radiography analysis

Author

Rudolph, Jan, Schachtner, Balthasar, Fink, Nicola, Koliogiannis, Vanessa, Schwarze, Vincent, Goller, Sophia, Trappmann, Lena, Hoppe, Boj F., Mansour, Nabeel, Fischer, Maximilian, Ben Khaled, Najib, Jörgens, Maximilian, Dinkel, Julien, Kunz, Wolfgang G., Ricke, Jens, Ingrisch, Michael, Sabel, Bastian O., and Rueckel, Johannes

Published
2022
Full Text
View/download PDF

45. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers

Author

Fournier, Laure, Costaridou, Lena, Bidaut, Luc, Michoux, Nicolas, Lecouvet, Frederic E., de Geus-Oei, Lioe-Fee, Boellaard, Ronald, Oprea-Lager, Daniela E., Obuchowski, Nancy A, Caroli, Anna, Kunz, Wolfgang G., Oei, Edwin H., O’Connor, James P. B., Mayerhoefer, Marius E., Franca, Manuela, Alberich-Bayarri, Angel, Deroose, Christophe M., Loewe, Christian, Manniesing, Rashindra, Caramella, Caroline, Lopci, Egesta, Lassau, Nathalie, Persson, Anders, Achten, Rik, Rosendahl, Karen, Clement, Olivier, Kotter, Elmar, Golay, Xavier, Smits, Marion, Dewey, Marc, Sullivan, Daniel C., van der Lugt, Aad, deSouza, Nandita M., and European Society of Radiology

Published
2021
Full Text
View/download PDF

46. Aβ status assessment in a hypothetical scenario prior to treatment with disease‐modifying therapies: Evidence from 10‐year real‐world experience at university memory clinics.

Author

Brendel, Matthias, Parvizi, Tandis, Gnörich, Johannes, Topfstedt, Christof Elias, Buerger, Katharina, Janowitz, Daniel, Rauchmann, Boris‐Stephan, Perneczky, Robert, Kurz, Carolin, Mehrens, Dirk, Kunz, Wolfgang G., Kusche‐Palenga, Julia, Kling, Agnes Bernadette, Buchal, Antonia, Nestorova, Elizabet, Silvaieh, Sara, Wurm, Raphael, Traub‐Weidinger, Tatjana, Klotz, Sigrid, and Regelsberger, Günther

Subjects
POSITRON emission tomography, RECEIVER operating characteristic curves, ALZHEIMER'S disease, CEREBROSPINAL fluid, MEDICAL protocols
Abstract

INTRODUCTION: With the advent of disease‐modifying therapies, accurate assessment of biomarkers indicating the presence of disease‐associated amyloid beta (Aβ) pathology becomes crucial in patients with clinically suspected Alzheimer's disease (AD). We evaluated Aβ levels in cerebrospinal fluid (Aβ CSF) and Aβ levels in positron emission tomography (Aβ PET) biomarkers in a real‐world memory‐clinic setting to develop an efficient algorithm for clinical use. METHODS: Patients were evaluated for AD‐related Aβ pathology from two independent cohorts (Ludwig Maximilian University [LMU], n = 402, and Medical University of Vienna [MUV], n = 144). Optimal thresholds of CSF biomarkers were deduced from receiver operating characteristic curves and validated against Aβ PET positivity. RESULTS: In both cohorts, a CSF Aβ42/40 ratio ≥ 7.1% was associated with a low risk of a positive Aβ PET scan (negative predictive value: 94.3%). Implementing two cutoffs revealed 14% to 16% of patients with intermediate results (CSF Aβ42/40 ratio: 5.5%–7.1%), which had a strong benefit from Aβ PET imaging (44%–52% Aβ PET positivity). DISCUSSION: A two‐cutoff approach for CSF Aβ42/40 including Aβ PET imaging at intermediate results provides an effective assessment of Aβ pathology in real‐world settings. Highlights: We evaluated cerebrospinal fluid (CSF) and positron emission tomography (PET) amyloid beta (Aβ) biomarkers for Alzheimer's disease in real‐world cohorts.A CSF Aβ 42/40 ratio between 5.5% and 7.1% defines patients at borderline levels.Patients at borderline levels strongly benefit from additional Aβ PET imaging.Two‐cutoff CSF Aβ 42/40 and PET will allow effective treatment stratification. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

48. Inter-hospital transfer for mechanical thrombectomy within the supraregional stroke network NEVAS

Author

Feil, Katharina, Rémi, Jan, Küpper, Clemens, Herzberg, Moriz, Dorn, Franziska, Kunz, Wolfgang G., Reidler, Paul, Levin, Johannes, Hüttemann, Katrin, Tiedt, Steffen, Heidger, Wanja, Müller, Katharina, Thunstedt, Dennis C., Dabitz, Rainer, Müller, Robert, Pfefferkorn, Thomas, Hamann, Gerhard F., Liebig, Thomas, Dieterich, Marianne, and Kellert, Lars

Published
2021
Full Text
View/download PDF

49. Evaluation of magnetic resonance thermometry performance during MR-guided hyperthermia treatment of soft-tissue sarcomas in the lower extremities and pelvis

Author

Karkavitsas, Spyridon N., Göger-Neff, Marianne, Kawula, Maria, Sumser, Kemal, Zilles, Benjamin, Wadepohl, Martin, Landry, Guillaume, Kurz, Christopher, Kunz, Wolfgang G., Dietrich, Olaf, Lindner, Lars H., Paulides, Margarethus M., Karkavitsas, Spyridon N., Göger-Neff, Marianne, Kawula, Maria, Sumser, Kemal, Zilles, Benjamin, Wadepohl, Martin, Landry, Guillaume, Kurz, Christopher, Kunz, Wolfgang G., Dietrich, Olaf, Lindner, Lars H., and Paulides, Margarethus M.

Abstract

Introduction: This study evaluated the performance of magnetic resonance thermometry (MRT) during deep-regional hyperthermia (HT) in pelvic and lower-extremity soft-tissue sarcomas. Materials and methods: 17 pelvic (45 treatments) and 16 lower-extremity (42 treatments) patients underwent standard regional HT and chemotherapy. Pairs of double-echo gradient-echo scans were acquired during the MR protocol 1.4 s apart. For each pair, precision was quantified using phase data from both echoes (‘dual-echo’) or only one (‘single-echo’) in- or excluding body fat pixels in the field drift correction region of interest. The precision of each method was compared to that of the MRT approach using a built-in clinical software tool (SigmaVision). Accuracy was assessed in three lower-extremity patients (six treatments) using interstitial temperature probes. The Jaccard coefficient quantified pretreatment motion; receiver operating characteristic analysis assessed its predictability for acceptable precision (<1 °C) during HT. Results: Compared to the built-in dual-echo approach, single-echo thermometry improved the mean temporal precision from 1.32 ± 0.40 °C to 1.07 ± 0.34 °C (pelvis) and from 0.99 ± 0.28 °C to 0.76 ± 0.23 °C (lower extremities). With body fat-based field drift correction, single-echo mean accuracy improved from 1.4 °C to 1.0 °C. Pretreatment bulk motion provided excellent precision prediction with an area under the curve of 0.80–0.86 (pelvis) and 0.81–0.83 (lower extremities), compared to gastrointestinal air motion (0.52–0.58). Conclusion: Single-echo MRT exhibited better precision than dual-echo MRT. Body fat-based field-drift correction significantly improved MRT accuracy. Pretreatment bulk motion showed improved prediction of acceptable MRT temporal precision over gastrointestinal air motion.

Published
2024

50. Costs and health effects of CT perfusion-based selection for endovascular thrombectomy within 6 hours of stroke onset: a model-based health economic evaluation

Author

Van Voorst, Henk, Hoving, Jan W., Koopman, Miou S., Daems, Jasper D., Peerlings, Daan, Buskens, Erik, Lingsma, Hester, Marquering, Henk A., De Jong, Hugo W.A.M., Berkhemer, Olvert A., Van Zwam, Wim H., Van Walderveen, Marianne A.A., Van Den Wijngaard, Ido R., Dippel, Diederik W.J., Yoo, Albert J., Campbell, Bruce, Kunz, Wolfgang G., Majoie, Charles B., Emmer, Bart J., Staals, Julie, de Ridder, Inger, van Oostenbrugge, Robert Jan, Postma - Jacobi, Linda, van der Leij, Christiaan, Brans, Rutger, Pirson, Anne-France, Olthuis, Susanne, Pinckaers, Floor, Hinsenveld, Wouter, Goldhoorn, Robert-Jan, Truijman, Martine, ten Cate, Hugo, CLEOPATRA Investigators, MR CLEAN Registry Investigators, Van Voorst, Henk, Hoving, Jan W., Koopman, Miou S., Daems, Jasper D., Peerlings, Daan, Buskens, Erik, Lingsma, Hester, Marquering, Henk A., De Jong, Hugo W.A.M., Berkhemer, Olvert A., Van Zwam, Wim H., Van Walderveen, Marianne A.A., Van Den Wijngaard, Ido R., Dippel, Diederik W.J., Yoo, Albert J., Campbell, Bruce, Kunz, Wolfgang G., Majoie, Charles B., Emmer, Bart J., Staals, Julie, de Ridder, Inger, van Oostenbrugge, Robert Jan, Postma - Jacobi, Linda, van der Leij, Christiaan, Brans, Rutger, Pirson, Anne-France, Olthuis, Susanne, Pinckaers, Floor, Hinsenveld, Wouter, Goldhoorn, Robert-Jan, Truijman, Martine, ten Cate, Hugo, CLEOPATRA Investigators, and MR CLEAN Registry Investigators

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results